Kevin Bitterman sold $1.9M of IRON
director at Disc Medicine, Inc.. 27,136 shares at an average of $70.11, traded Sep 11, 2026, filed Sep 15, 2026.
Score components
- +15RoleDirector
- +25Trade size$1.9M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001591747-26-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | MOption exercise Common Stock | +7,136 | $45.69 | $326k | 7,136 | 27 d ago |
| Sep 11, 2026 | MOption exercise Common Stock | +10,000 | $38.85 | $389k | 17,136 | 27 d ago |
| Sep 11, 2026 | MOption exercise Common Stock | +10,000 | $50.86 | $509k | 27,136 | 27 d ago |
| Sep 11, 2026 | SOpen-market sale Common Stock | -27,136 | $70.11 | $1.9M | 0 | 27 d ago |
| Sep 11, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -7,136 | $0.00 | $0 | 0 | 27 d ago |
| Sep 11, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 0 | 27 d ago |
| Sep 11, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 0 | 27 d ago |
Related signals
Other insiders at Disc Medicine, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $135k 1,689 shares | -1% | |
| 25Weak | Disc Medicine, Inc. | Kevin Bitterman director | $4.4M 54,496 shares | -16% | |
| 20Weak | Disc Medicine, Inc. | Jean M. Franchi Chief Financial Officer | $105k 2,000 shares | -3% | |
| 14Weak | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $150k 2,996 shares | -5% | |
| 15Weak | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $334k 6,677 shares | -10% | |
| 5Weak | Disc Medicine, Inc. | William Jacob Savage Chief Medical Officer | $105k 2,100 shares | -3% | |
| 37Weak | Disc Medicine, Inc. | Mona Ashiya director | $310k 5,738 shares | -1% | |
| 37Weak | Disc Medicine, Inc. | Orbimed Advisors LLC director | $310k 5,738 shares | -1% | |
| 53Moderate | Disc Medicine, Inc. | Mona Ashiya director | $2.8M 52,429 shares | -10% | |
| 53Moderate | Disc Medicine, Inc. | Orbimed Advisors LLC director | $2.8M 52,429 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.